Aeris Biotechnologies, Inc. — Regulation A 1-A
Aeris Biotechnologies, Inc. of Plano, TX filed a Regulation A 1-A with the SEC on 2022-04-25. Aggregate offering: $15.0M (Tier 2). Industry: Other.
Offering
- Filed: 2022-04-25
- Form: 1-A
- Accession: 0001829126-22-008698
- Tier: Tier 2
- Total aggregate offering: $15.0M
- Issuer portion: $15.0M
- Price per security: $1.0000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: BF Borgers CPA PC
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001907923
- Organized in: DE
- Incorporated: 2021
- Address: 8105 Rasor Boulevard, Plano, TX, 75024
- Phone: 1-214-436-2986
- Employees: 2 full-time, 1 part-time
Financial snapshot (as filed)
- Total assets: $33K
- Cash & equivalents: $33K
- Total liabilities: $105K
- Stockholder equity: $-71K
People (1)
| Name | Role | Location |
|---|
| Stephen E. Fox | Signer | Plano, TX |
Other Reg A filings by this issuer (3)
More